Trial Profile
Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Middle or Lower Thoracic Esophageal Squamous Cell Carcinoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Mar 2022
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Oesophageal cancer; Squamous cell cancer; Thoracic neoplasms
- Focus Biomarker; Pharmacodynamics
- 16 Mar 2020 Planned primary completion date changed from 1 Apr 2017 to 1 Jul 2020.
- 08 Jul 2014 New trial record